MDLinx Conference Coverage – July 2016

The MDLinx editors covered 4 interesting medical conferences during the month of July with a focus on dermatology, AIDS, ENT, cancer, and gastrointestinal cancer. Some of the highlights follow. As reported at the ESMO 18th World Congress on Gastrointestinal Cancer held in Barcelona, Spain, June 29–July 2 July, anti-IL-1α antibody is effective in patients with metastatic colorectal cancer who have failed standard therapy (oxaliplatin and irinotecan). Patients treated with anti-IL-1α monoclonal antibody (n=207) had a 33% treatment responsecompared with 19% in patients treated with placebo. There was also a 26% relative risk reduction in adverse events. Use of a free […]

See What You Missed at the June Medical Conferences

In the month of June, the MDLinx editors covered a number of interesting conferences in a number of specialties, including neurology, oncology, rheumatology, and endocrinology. Here are some of the studies that were presented at those conferences. The 2016 Annual Meeting of the Consortium of Multiple Sclerosis Centers was held in Baltimore, MD June 1-4, 2016. The OPERA I and II investigators presented findings on the effect of ocrelizumab (OCR), an anti-CD20+ B cell monoclonal antibody, on specific humoral immunity in two identical phase 3, randomized, double-blind, double-dummy, interferon beta-1a (IFNβ-1a)-controlled trials involving patients with relapsing multiple sclerosis. The article […]

MDLinx Conference Coverage – May 2016

The MDLinx editors had a busy month in May, covering a total of 11 medical conferences with a focus on endocrinology, oncology, gastroenterology, psychiatry, obstetrics & gynecology, pulmonology, pain, urology, and ophthalmology. Here is a review of some of the highlights. The 41st Annual Congress of Oncology Nursing Society met in San Antonio, TX April 28–May 1. In one study, rolapitant (180 mg 1-2 h before chemotherapy), a neurokinin-1 receptor antagonist, was shown to reduce nausea in patients receiving cisplatin- and carboplatin-based chemotherapy, and thus improve quality of life. The 13th International Conference on Obesity was held in Vancouver, British […]

May is National Asthma Awareness Month

Some interesting facts about Asthma from the World Health Organization – WHO estimates show that 235 million people currently suffer from asthma. Asthma deaths will increase in the next 10 years if urgent action is not taken. Asthma cannot be cured, but proper diagnosis, treatment and patient education can result in good asthma control and management. Asthma occurs in all countries regardless of level of development. Over 80% of asthma deaths occur in low and lower-middle income countries. For effective control, it is essential to make medications affordable and available, especially for low-income families. Asthma is a chronic disease characterized […]

Weekend Review – March 14, 2016

What can you find on MDLinx this weekend? What is a weekend without a little intrigue? This weekend is no exception with a number of interesting articles and features on MDLinx. Featured Articles Scientists are looking at a new approach to design a small-molecule drug that targets the specific cancer-causing RNA of one of the hardest to treat cancers. Find out which one it is. Discover what the latest research is showing about the use of proton pump inhibitors in this video from Houston Methodist Research Institute. How can retinal scans help detect Alzheimer’s disease? Take a look at the […]

Weekend Review

What can you find on MDLinx this weekend? This weekend, MDLinx has a number of things going on. Conference Coverage For example, we have conference coverage of the American Urological Association conference going on in San Diego, CA from today (May 6th) until next Tuesday (May 10th). You can also take a look at other conference coverage you may have missed from the 13th International Conference on Obesity (ICO) from Vancouver, BC, Canada; the Oncology Nursing Society 41st Annual Congress, which took place in San Antonio, TX; as well as coverage from the American Association of Cancer Research Annual Meeting […]

Where do you stand with your physical activity goals?

Now that spring is here, you have to ask yourself a question: Are you active enough? Were you among the group of adults in the United States who met federal guidelines for aerobic physical activity? In an assessment of physical activity done by the Centers for Disease Control and Prevention as part of the National Health Interview Survey, respondents were considered to be meeting aerobic activity guidelines if they reported moderate-intensity physical activity for at least 150 minutes of leisure-time activity per week, vigorous-intensity physical activity for ≥75 minutes of leisure-time activity per week, or an equivalent combination of moderate-intensity […]

Is the flu season over in your area?

The influenza season continues to abate but remains slightly elevated as April ends, according to a report from the Centers for Disease Control and Prevention. The report points out that while flu activity has peaked nationally for this season, some parts of the country are still experiencing widespread flu activity and an increasing proportion of influenza B viruses have been detected. Second waves of influenza B activity occur during many flu seasons, they explained. Flu activity is expected to continue for a number of weeks. Six pediatric deaths were reported this week, bringing the total number of pediatric deaths attributed […]

What conferences did you miss in March? The latest on the better chemotherapy, weekend mortality rates, peanut allergy, and more.

In March, MDLinx editors covered a number of interesting and cutting edge conferences, including women’s cancer, hospital medicine, allergy, dermatology, and orthopedic surgery. Here are some of the studies you might have missed. As reported at the 47th Annual Meeting of the Society of Gynecologic Oncology on Women’s Cancer in San Diego, CA (March 19-22, 2016), Joan L. Walker, MD, from the Stephenson Cancer Center Gynecologic Cancers Clinic at Oklahoma University, Oklahoma City, found that compared with intravenous chemotherapy, intraperitoneal chemotherapydoes not improve progression-free survival (PFS) in women with stage II and III ovarian, fallopian tube, or peritoneal carcinoma who have […]

What conferences did you miss in February? Review them here.

In the last month, MDLinx editors covered a number of interesting and cutting edge conferences, including those on retroviruses and opportunistic infections, critical care medicine, pain medicine, multiple sclerosis, rheumatology, and stroke. Highlights of some of these conferences are described here. As reported at the 23rd Conference on Retroviruses and Opportunistic Infections, which was held in Boston, MA, February 22-25, between 2004 and 2010, the percentage of HIV-positive patients who were screened for Neisseria (NG) and Chlamydia (CT) increased from 22% to 39%. “As NG/CT testing increased, the test positivity also increased, yielding an overall improvement in case detection in […]